Procalcitonin-guided antibiotic therapy: A systematic review and meta-analysis

被引:59
作者
Soni, Nilam J. [1 ]
Samson, David J. [2 ]
Galaydick, Jodi L. [3 ]
Vats, Vikrant [2 ]
Huang, Elbert S. [4 ]
Aronson, Naomi [2 ]
Pitrak, David L. [5 ]
机构
[1] Univ Texas Hlth Sci Ctr San Antonio, Div Hosp Med, Dept Med, San Antonio, TX 78229 USA
[2] Evidence Based Practice Ctr, Blue Cross & Blue Shield Assoc, Technol Evaluat Ctr, Chicago, IL USA
[3] Icahn Sch Med Mt Sinai, Dept Surg, Div Crit Care Med, New York, NY USA
[4] Univ Chicago, Dept Med, Sect Gen Internal Med, Chicago, IL 60637 USA
[5] Univ Chicago, Dept Med, Sect Infect Dis & Global Hlth, Chicago, IL 60637 USA
基金
美国医疗保健研究与质量局;
关键词
RESPIRATORY-TRACT INFECTIONS; VENTILATOR-ASSOCIATED PNEUMONIA; INTENSIVE-CARE PATIENTS; SERUM PROCALCITONIN; GUIDANCE; SEPSIS; ALGORITHMS; BIOMARKERS; GUIDELINES; REDUCTION;
D O I
10.1002/jhm.2067
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: The utility of procalcitonin to manage patients with infections is unclear. A systematic review of comparative studies using procalcitonin-guided antibiotic therapy in patients with infections was performed. METHODS: Randomized, controlled trials comparing procalcitonin-guided initiation, intensification, or discontinuation of antibiotic therapy to clinically guided therapy were included. Outcomes were antibiotic usage, morbidity, and mortality. MEDLINE, EMBASE, the Cochrane Database, National Institute for Clinical Excellence, the National Guideline Clearinghouse, and the Health Technology Assessment Programme were searched from January 1, 1990 to December 16, 2011. RESULTS: Eighteen randomized, controlled trials were included. Data were pooled into clinically similar patient populations. In adult intensive care unit (ICU) patients, procalcitonin-guided discontinuation of antibiotics reduced antibiotic duration by 2.05 days (95% confidence interval [CI]: -2.59 to -1.52) without increasing morbidity or mortality. In contrast, procalcitonin-guided intensification of antibiotics in adult ICU patients increased antibiotic usage and morbidity. In adult patients with respiratory tract infections, procalcitonin guidance significantly reduced antibiotic duration by 2.35 days (95% CI: -4.38 to -0.33), antibiotic prescription rate by 22% (95% CI: -41% to -4%), and total antibiotic exposure without affecting morbidity or mortality. A single, good quality study of neonates with suspected sepsis demonstrated reduced antibiotic duration by 22.4 hours (P=0.012) and reduced the proportion of neonates on antibiotics for 72 hours by 27% (P=0.002) with procalcitonin guidance. CONCLUSION: Procalcitonin guidance can safely reduce antibiotic usage when used to discontinue antibiotic therapy in adult ICU patients and when used to initiate or discontinue antibiotics in adult patients with respiratory tract infections. Journal of Hospital Medicine 2013;8:530-540. (c) 2013 Society of Hospital Medicine
引用
收藏
页码:530 / 540
页数:11
相关论文
共 45 条
[1]   Procalcitonin to Guide Duration of Antimicrobial Therapy in Intensive Care Units: A Systematic Review [J].
Agarwal, Rajender ;
Schwartz, David N. .
CLINICAL INFECTIOUS DISEASES, 2011, 53 (04) :379-387
[2]  
Albrich WC, 2012, ARCH INTERN MED, V172, P715, DOI 10.1001/archinternmed.2012.770
[3]  
[Anonymous], 2011, AHRQ PUBLICATION
[4]   Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial [J].
Bouadma, Lila ;
Luyt, Charles-Edouard ;
Tubach, Florence ;
Cracco, Christophe ;
Alvarez, Antonio ;
Schwebel, Carole ;
Schortgen, Frederique ;
Lasocki, Sigismond ;
Veber, Benoit ;
Dehoux, Monique ;
Bernard, Maguy ;
Pasquet, Blandine ;
Regnier, Bernard ;
Brun-Buisson, Christian ;
Chastre, Jean ;
Wolff, Michel .
LANCET, 2010, 375 (9713) :463-474
[5]   Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care [J].
Briel, Matthias ;
Schuetz, Philipp ;
Mueller, Beat ;
Young, Jim ;
Schild, Ursula ;
Nusbaumer, Charly ;
Periat, Pierre ;
Bucher, Heiner C. ;
Christ-Crain, Mirjam .
ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (18) :2000-2007
[6]   Kinetics of procalcitonin in iatrogenic sepsis [J].
Brunkhorst, FM ;
Heinz, U ;
Forycki, ZF .
INTENSIVE CARE MEDICINE, 1998, 24 (08) :888-889
[7]   Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection [J].
Burkhardt, O. ;
Ewig, S. ;
Haagen, U. ;
Giersdorf, S. ;
Hartmann, O. ;
Wegscheider, K. ;
Hummers-Pradier, E. ;
Welte, T. .
EUROPEAN RESPIRATORY JOURNAL, 2010, 36 (03) :601-607
[8]   Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years [J].
Carling, P ;
Fung, T ;
Killion, A ;
Terrin, N ;
Barza, M .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2003, 24 (09) :699-706
[9]   Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults - A randomized trial [J].
Chastre, J ;
Wolff, M ;
Fagon, JY ;
Chevret, S ;
Thomas, F ;
Wermert, D ;
Clementi, E ;
Gonzalez, J ;
Jusserand, D ;
Asfar, P ;
Perrin, D ;
Fieux, F ;
Aubas, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (19) :2588-2598
[10]   Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates [J].
Chiesa, C ;
Panero, A ;
Rossi, N ;
Stegagno, M ;
De Giusti, M ;
Osborn, JF ;
Pacifico, L .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (03) :664-672